BARON BRAND



Trademark Coverage

No Class Specified

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating and preventing tendon and muscle injuries and disorders, sports related injuries, and for knee cartilage regeneration; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations, namely, an analgesic for human consumption taken orally; Pharmaceutical preparations, namely, anticoagulants; Pharmaceutical preparations, namely, antidepressants; Pharmaceutical preparations, namely, appetite suppressants; Pharmaceutical preparations, namely, dantrolene sodium for injection; Pharmaceutical preparations, namely, injectable contraceptives; Pharmaceutical products and preparations against dry skin caused by pregnancy; Pharmaceutical products and preparations for chloasma; Pharmaceutical products and preparations for hydrating the skin during pregnancy; Pharmaceutical products and preparations for pregnancy blemishes; Pharmaceutical products and preparations for preventing skin blemishes during pregnancy; Pharmaceutical products and preparations to prevent stretch marks; Pharmaceutical products and preparations to prevent swelling in the legs; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for the treatment of joint disease; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma; and Pharmaceutical skin lotions

Owner

ABCO Laboratories, Inc.

Business in Fairfield, CA

Owns 45 trademarks

Timeline
  • Feb 04
    2013
    Abandonment Notice Mailed No Use Statement Filed
  • Feb 04
    2013
    Abandonment No Use Statement Filed
  • Jul 11
    2012
    Notice Of Approval Of Extension Request E Mailed
  • Jul 10
    2012
    Extension 2 Granted
  • Jul 05
    2012
    Extension 2 Filed
  • Jul 09
    2012
    Notice Of Revival E Mailed
  • Jul 07
    2012
    Extension Received With TEAS Petition
  • Jul 07
    2012
    Petition To Revive Granted
  • Jul 07
    2012
    TEAS Petition To Revive Received
  • Dec 16
    2011
    Notice Of Approval Of Extension Request E Mailed
  • Dec 14
    2011
    Extension 1 Granted
  • Dec 14
    2011
    Extension 1 Filed
  • Dec 14
    2011
    TEAS Extension Received
  • Jul 05
    2011
    NOA E Mailed SOU Required From Applicant
  • May 10
    2011
    Official Gazette Publication Confirmation E Mailed
  • May 10
    2011
    Published For Opposition
  • Apr 07
    2011
    Law Office Publication Review Completed
  • Apr 01
    2011
    Approved For PUB Principal Register
  • Mar 29
    2011
    TEAS/Email Correspondence Entered
  • Mar 28
    2011
    Correspondence Received In Law Office
  • Mar 28
    2011
    TEAS Request For Reconsideration Received
  • Mar 24
    2011
    Notification Of Final Refusal Emailed
  • Mar 24
    2011
    Final Refusal E Mailed
  • Mar 24
    2011
    Final Refusal Written
  • Mar 08
    2011
    Divisional Processing Complete
  • Mar 03
    2011
    Divisional Request Received
  • Mar 03
    2011
    TEAS Request To Divide Received
  • Mar 02
    2011
    ITU Office Action Issued For Divisional Request
  • Mar 01
    2011
    Case Assigned To Intent To Use Paralegal
  • Feb 28
    2011
    TEAS/Email Correspondence Entered
  • Feb 28
    2011
    Correspondence Received In Law Office
  • Feb 16
    2011
    Assigned To LIE
  • Feb 08
    2011
    TEAS Response To Office Action Received
  • Dec 24
    2010
    Notification Of Non Final Action E Mailed
  • Dec 24
    2010
    Non Final Action E Mailed
  • Dec 24
    2010
    Non Final Action Written
  • Dec 22
    2010
    Assigned To Examiner
  • Sep 20
    2010
    New Application Office Supplied Data Entered In TRAM
  • Sep 18
    2010
    New Application Entered In TRAM